Randomized phase II study of bortezomib alone and bortezomib in combination with docetaxel in previously treated advanced non-small-cell lung cancer

Michael P. Fanucchi, Frank V. Fossella, Robert Belt, Ronald Natale, Panos Fidias, David P. Carbone, Ramaswamy Govindan, Luis E. Raez, Francisco Robert, Maria Ribeiro, Wallace Akerley, Karen Kelly, Steven A. Limentani, Jeffrey Crawford, Hans Joachim Reimers, Rita Axelrod, Oscar Kashala, Shihong Sheng, Joan H. Schiller

Research output: Contribution to journalArticlepeer-review

149 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized phase II study of bortezomib alone and bortezomib in combination with docetaxel in previously treated advanced non-small-cell lung cancer'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology